SYNTHESIS AND BINDING-PROPERTIES OF THE FLUORINATED SUBSTITUTED BENZAMIDE [H-3] NCQ-115, A NEW SELECTIVE DOPAMINE-D2 RECEPTOR LIGAND

被引:16
作者
HALL, H [1 ]
HOGBERG, T [1 ]
HALLDIN, C [1 ]
BENGTSSON, S [1 ]
WEDEL, I [1 ]
机构
[1] ASTRA RES CTR AB,CNS2 RES & DEV,S-15185 SODERTALJE,SWEDEN
关键词
BENZAMIDES; (FLUORINATED; SUBSTITUTED); DOPAMINE-D2; RECEPTORS; RECEPTOR BINDING (INVITRO);
D O I
10.1016/0014-2999(91)90315-H
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[H-3]NCQ 115 ((R)-5-bromo-2,3-dimethoxy-N-((1-([2,5-H-3]-4-fluorobenzyl)-2-pyrrolidinyl)methyl)benzamide) was prepared by acylation of (R)-(2-aminomethyl)-1-([2,5-H-3]-4-fluorobenzyl)pyrrolidine, which was obtained in a stereoconservative synthesis from (R)-prolinamide. Purification by reversed phase high performance liquid chromatography (HPLC) gave [H-3]NCQ 115 with a radiochemical purity of > 99% and a specific activity of 0.97 GBq/mu-mol (36 Ci/mmol). Saturation analyses, association and dissociation kinetics as well as binding competition with several compounds of various classes were performed with [H-3]NCQ 115 in rat striatal homogenates. Saturation analyses in vitro showed that [H-3]NCQ 115 bound to a single binding site with a K(d) = 214 pM and B(max), = 35.4 fmol/mg. The binding of [H-3]NCQ 115 was dependent upon sodium ions, since the number of binding sites was altered when sodium ions were excluded from the incubation medium. NCQ 115 inhibited the binding of [H-3]raclopride to dopamine D2 receptors with high affinity (K(i) = 147 pM), having much lower affinity for other receptors. The affinity of this substituted 1-benzyl-2-pyrrolidinylmethyl benzamide was confined to the (R)-enantiomer, which contrasts with that of the corresponding N-ethyl derivatives such as FLB 457, raclopride, eticlopride, sulpiride and NCQ 298, where the pharmacological activity is found in the (S)-enantiomer. It can be concluded that [H-3]NCQ 115 binds to dopamine D2 receptors in the rat striatum with high affinity and high selectivity. [H-3]NCQ 115 can also be used for in vivo binding studies of the brain. [F-18]NCQ 115 may be a suitable ligand for positron emission tomography (PET) studies of the human brain in vivo.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 46 条
[41]   BIMODAL DISTRIBUTION OF DOPAMINE RECEPTOR DENSITIES IN BRAINS OF SCHIZOPHRENICS [J].
SEEMAN, P ;
ULPIAN, C ;
BERGERON, C ;
RIEDERER, P ;
JELLINGER, K ;
GABRIEL, E ;
REYNOLDS, GP ;
TOURTELLOTTE, WW .
SCIENCE, 1984, 225 (4663) :728-731
[42]   THE MAJOR DOPAMINE D2-RECEPTOR - MOLECULAR ANALYSIS OF THE HUMAN D2A-SUBTYPE [J].
SELBIE, LA ;
HAYES, G ;
SHINE, J .
DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY, 1989, 8 (09) :683-689
[43]   MOLECULAR-CLONING AND CHARACTERIZATION OF A NOVEL DOPAMINE RECEPTOR (D3) AS A TARGET FOR NEUROLEPTICS [J].
SOKOLOFF, P ;
GIROS, B ;
MARTRES, MP ;
BOUTHENET, ML ;
SCHWARTZ, JC .
NATURE, 1990, 347 (6289) :146-151
[44]   CATION REGULATION DIFFERENTIATES SPECIFIC BINDING OF [SULPIRIDE-H-3 AND [SPIPERONE-H-3 TO RAT STRIATAL PREPARATIONS [J].
THEODOROU, AE ;
HALL, MD ;
JENNER, P ;
MARSDEN, CD .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1980, 32 (06) :441-444
[45]   1,3-DI(2-[5-H-3]TOLYL)GUANIDINE - A SELECTIVE LIGAND THAT LABELS SIGMA-TYPE RECEPTORS FOR PSYCHOTOMIMETIC OPIATES AND ANTIPSYCHOTIC-DRUGS [J].
WEBER, E ;
SONDERS, M ;
QUARUM, M ;
MCLEAN, S ;
POU, S ;
KEANA, JFW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (22) :8784-8788
[46]   QUANTITATIVE-ANALYSIS OF DRUG-RECEPTOR INTERACTIONS .1. DETERMINATION OF KINETIC AND EQUILIBRIUM PROPERTIES [J].
WEILAND, GA ;
MOLINOFF, PB .
LIFE SCIENCES, 1981, 29 (04) :313-330